Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cephalon initiates testing of modafinil for excessive daytime sleepiness in sleep apnea sufferers

May 12, 1999

Paxil approved in two major markets for social anxiety disorder

May 12, 1999

Anesta enters partnership with Swedish Orphan for Actiq

May 12, 1999

Safe, dose-dependent MAO-B inhibition in healthy volunteers administered SL-34.0026

May 11, 1999

Potential anxiolytics/antidepressants under development at DuPont

May 11, 1999

Substituted indan derivatives with selective affinity for 5-HT1B receptors

May 11, 1999

Single-isomer valproic acid patented in Japan

May 10, 1999

Licensing opportunity from NIH: BChE inhibitors for Alzheimer's disease Rx, Dx

May 10, 1999

Amarillo's fibromyalgia trial expanded

May 10, 1999

Caspase inhibitor provides neuroprotection in rabbit model of bacterial meningitis

May 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...